Cetiriz D 5 mg/120 mg Tablet
By Cetiriz D
Rx
10 Tablet in a Strip

Composition
Cetirizine(5mg) + Pseudoephedrine(120mg)

Manufacturer - Alkem Laboratories Ltd
Alkem Laboratories Limited, Devashish Building, Alkem House, Senapati Bapat Road, Lower Parel, Mumbai - 400 013.

Expires on or after
August, 2025

liver
Cetiriz D 5 mg/120 mg Tablet is considered to be generally safe for individuals with liver disease based on the available data. It is likely that no dosage adjustments for Cetiriz D 5 mg/120 mg Tablet are necessary for patients with liver conditions. However, it is still crucial to discuss your situation with your healthcare provider for personalized advice. For Cetiriz Tablet 10's, there is limited information specifically regarding its use in patients with liver impairment. If you have any worries about using Cetiriz Tablet 10's with liver issues, it is recommended to speak with your doctor. Your doctor will assess the potential benefits against the possible risks before prescribing this medication. Remember, always consult your doctor for appropriate guidance before starting or continuing with the use of Cetiriz D 5 mg/120 mg Tablet or Cetiriz Tablet 10's, especially if you have liver concerns.

kidney
Cetiriz D 5 mg/120 mg Tablet should be used carefully in patients with kidney issues. Dose adjustment may be necessary, so it is crucial to consult your doctor. Avoid using if you have severe kidney disease or undergoing hemodialysis.

alcohol
Cetiriz D 5 mg/120 mg Tablet can lead to increased drowsiness if consumed with alcohol. Avoid alcohol intake with this medication.

driving
Cetiriz D 5 mg/120 mg Tablet typically does not impact driving ability. However, it is advised to drive carefully as Cetiriz Tablet 10's may affect driving skills in some cases.

pregnancy
It is better to consult your doctor before using Cetiriz D 5 mg/120 mg Tablet during pregnancy. Cetiriz Tablet 10's is generally safe, but it's advised to discuss any concerns with your doctor first.

breastfeeding
Caution should be exercised when using Cetiriz D 5 mg/120 mg Tablet while breastfeeding, as it may be unsafe. Limited data indicates potential harm to the baby through breastmilk. Consider benefits versus risks with a healthcare provider.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | RESPIRATORY |
Action Class | - |
₹19.62
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024